Stromal immune cells expression of Siglec-15 is associated with lower T stage and better prognosis of urinary bladder cancer
This study revealed a high expression rate of Siglec-15 in BC and may provide valuable insights for patient selection in future clinical trials.
Authors
- Yao Fu (ORCID: https://orcid.org/0000-0002-5855-4706)
- Jun Yang (ORCID: https://orcid.org/0000-0001-7157-304X)
- Jiong Shi (ORCID: https://orcid.org/0000-0002-8684-4268)
- Xiangshan Fan
- Chengbiao Chu
Institutions
- Nanjing Drum Tower Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.3389/fonc.2024.1437006
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 0.00